• Human prostate tissue was stained with Anti-Prostate-Specific Membrane Antigen (ABT-PSMA) Antibody
  • Human prostatic adenocarcinoma tissue was stained with Anti-Prostate-Specific Membrane Antigen (ABT-PSMA) Antibody
  • Various whole cell lysates were separated by 12% SDS-PAGE, and the membrane was blotted with anti-PMSA antibody. The HRP-conjugated anti- mouse IgG antibody was used to detect the antibody. Predicted band size: 84 kDaObserved band size: 110 kDa
  • Whole cell lysates of LnCap were separated by 8% SDS-PAGE, and the membrane was blotted with anti-PSMA antibody. The HRP-conjugated anti- mouse IgG antibody was used to detect the antibody. Lane 1:Anti-PSMA antibody at 1ug/ml Lane 2:Anti-PSMA antibody at 0. 2ug/mlPredicted band size: 84 kDaObserved band size: 100 kDa

Anti-FOLH1 antibody (100-200 aa) [ABT-PSMA] (STJ196863)

SKU:
STJ196863

Current Stock:
Host: Mouse
Applications: IHC/WB
Reactivity: Human/Mouse/Rat
Note: STRICTLY FOR FURTHER SCIENTIFIC RESEARCH USE ONLY (RUO). MUST NOT TO BE USED IN DIAGNOSTIC OR THERAPEUTIC APPLICATIONS.
Short Description: Mouse monoclonal antibody anti-Glutamate carboxypeptidase 2 (100-200 aa) is suitable for use in Immunohistochemistry and Western Blot research applications.
Clonality: Monoclonal
Clone ID: ABT-PSMA
Conjugation: Unconjugated
Isotype: IgG1k
Formulation: Liquid in PBS containing 50% Glycerol, 0.5% BSA and 0.02% Sodium Azide.
Purification: The antibody was affinity-purified from mouse ascites by affinity-chromatography using specific immunogen.
Dilution Range: IHC-P 1:100-500
WB 1:500-2000
Storage Instruction: Store at-20°C for up to 1 year from the date of receipt, and avoid repeat freeze-thaw cycles.
Gene Symbol: FOLH1
Gene ID: 2346
Uniprot ID: FOLH1_HUMAN
Immunogen Region: 100-200 aa
Specificity: This antibody detects endogenous levels of human Prostate-Specific Membrane Antigen  (PSMA). Heat-induced epitope retrieval (HIER) Citrate buffer of pH6.0 was highly recommended as antigen repair metho
Immunogen: Synthesized peptide derived from the human Prostate-Specific Membrane Antigen  (PSMA) at the amino acid range 100-200
Post Translational Modifications The first two amino acids at the N-terminus of isoform PSMA' appear to be cleaved by limited proteolysis. The N-terminus is blocked.
Function Has both folate hydrolase and N-acetylated-alpha-linked-acidic dipeptidase (NAALADase) activity. Has a preference for tri-alpha-glutamate peptides. In the intestine, required for the uptake of folate. In the brain, modulates excitatory neurotransmission through the hydrolysis of the neuropeptide, N-aceylaspartylglutamate (NAAG), thereby releasing glutamate. Involved in prostate tumor progression. Also exhibits a dipeptidyl-peptidase IV type activity. In vitro, cleaves Gly-Pro-AMC.
Protein Name Glutamate Carboxypeptidase 2
Cell Growth-Inhibiting Gene 27 Protein
Folate Hydrolase 1
Folylpoly-Gamma-Glutamate Carboxypeptidase
Fgcp
Glutamate Carboxypeptidase Ii
Gcpii
Membrane Glutamate Carboxypeptidase
Mgcp
N-Acetylated-Alpha-Linked Acidic Dipeptidase I
Naaladase I
Prostate-Specific Membrane Antigen
Psm
Psma
Pteroylpoly-Gamma-Glutamate Carboxypeptidase
Database Links Reactome: R-HSA-8963693
Cellular Localisation Cell Membrane
Single-Pass Type Ii Membrane Protein
Isoform Psma': Cytoplasm
Alternative Antibody Names Anti-Glutamate Carboxypeptidase 2 antibody
Anti-Cell Growth-Inhibiting Gene 27 Protein antibody
Anti-Folate Hydrolase 1 antibody
Anti-Folylpoly-Gamma-Glutamate Carboxypeptidase antibody
Anti-Fgcp antibody
Anti-Glutamate Carboxypeptidase Ii antibody
Anti-Gcpii antibody
Anti-Membrane Glutamate Carboxypeptidase antibody
Anti-Mgcp antibody
Anti-N-Acetylated-Alpha-Linked Acidic Dipeptidase I antibody
Anti-Naaladase I antibody
Anti-Prostate-Specific Membrane Antigen antibody
Anti-Psm antibody
Anti-Psma antibody
Anti-Pteroylpoly-Gamma-Glutamate Carboxypeptidase antibody
Anti-FOLH1 antibody
Anti-FOLH antibody
Anti-NAALAD1 antibody
Anti-PSM antibody
Anti-PSMA antibody
Anti-GIG27 antibody

Information sourced from Uniprot.org

12 months for antibodies. 6 months for ELISA Kits. Please see website T&Cs for further guidance